Emerging Technologies & Major Leaders of the Global Neurovascular Devices Industry

The following are the major objectives of the study:

To define, describe, and forecast the global neurovascular devices market on the basis of product, disease pathology, and region.
To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, and opportunities)
To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
To strategically profile the key market players and comprehensively analyze their market shares and core competencies
To track and analyze competitive developments such as acquisitions, expansions, new product launches, agreements, and collaborations in the neurovascular devices/interventional neurology devices market

Download PDF Brochure@

The neurovascular devices market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Major factors driving the growth of this market include growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices.

Target Audience:

Original Equipment Manufacturers (OEMs)
Product Sales and Distribution Companies
Healthcare Service Providers (Hospitals and Surgical Centers)
Non-government Organizations
Government Regulatory Authorities
# Research Laboratories and Academic Institutes
Clinical Research Organizations (CROs)
Research and Development Companies
Market Research and Consulting Firms

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is the fastest-growing geographic segment in the neurovascular devices/interventional neurology market. 

The large market growth of this geographic segment can be attributed to the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The key players in the neurovascular devices/interventional neurology market focused on various strategies such as product launches & enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase market shares in the global market. Product launches & enhancements were the key strategies adopted by major industry players to achieve the desired market growth during 2013-2016.

Request Sample Pages@

This strategy was mainly adopted by Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China).

Apart from product launches & enhancements, many prominent players also adopted agreements & collaborations as the key growth strategy to strengthen market presence, enhance R&D capabilities, and to expand distribution networks to generate additional demand by sensitizing end users through an increase in availability of neurovascular products